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Abstract
Background: Dementia shows sex difference in its epidemiology. Childbirth, a distinctive experience of women, is
associated with the risk for various diseases. However, its association with the risk of dementia in women has rarely
been studied.
Methods: We harmonized and pooled baseline data from 11 population-based cohorts from 11 countries over 3
continents, including 14,792 women aged 60 years or older. We investigated the association between parity and
the risk of dementia using logistic regression models that adjusted for age, educational level, hypertension, diabetes
mellitus, and cohort, with additional analyses by region and dementia subtype.
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Results: Across all cohorts, grand multiparous (5 or more childbirths) women had a 47% greater risk of dementia
than primiparous (1 childbirth) women (odds ratio [OR] = 1.47, 95% confidence interval [CI] = 1.10–1.94), while
nulliparous (no childbirth) women and women with 2 to 4 childbirths showed a comparable dementia risk to
primiparous women. However, there were differences associated with region and dementia subtype. Compared to
women with 1 to 4 childbirths, grand multiparous women showed a higher risk of dementia in Europe (OR = 2.99,
95% CI = 1.38–6.47) and Latin America (OR = 1.49, 95% CI = 1.04–2.12), while nulliparous women showed a higher
dementia risk in Asia (OR = 2.15, 95% CI = 1.33–3.47). Grand multiparity was associated with 6.9-fold higher risk of
vascular dementia in Europe (OR = 6.86, 95% CI = 1.81–26.08), whereas nulliparity was associated with a higher risk
of Alzheimer disease (OR = 1.91, 95% CI 1.07–3.39) and non-Alzheimer non-vascular dementia (OR = 3.47, 95% CI =
1.44–8.35) in Asia.
Conclusion: Parity is associated with women’s risk of dementia, though this is not uniform across regions and
dementia subtypes.
Keywords: Dementia, Alzheimer’s disease, Risk factors, Parity, Women
Background
Dementia is one of many disorders with sex and gender
differences in epidemiology, risk factors, and outcomes.
Compared to men, women show a greater prevalence of
dementia [1], a higher risk of Alzheimer disease (AD)
conferred by the apolipoprotein ε4 allele [2], and faster
loss of autonomy after diagnosis of AD [3]. Pregnancy
and childbirth are distinctive experiences of women and
are associated with changes in hormone levels, health
conditions, and lifestyle that influence the risk of demen-
tia. For example, estrogen is closely associated with the
risk of AD and vascular dementia (VaD) [4], and its serum
level increases more than 10-fold in the third trimester of
pregnancy [4, 5]. A higher number of births is generally
associated with lower socioeconomical status and educa-
tional level, factors that may increase the risk of dementia
[6]. Additionally grand multiparity (5 or more childbirths)
increases the chances of developing hypertension, coron-
ary heart disease, and diabetes mellitus (DM) [7–9], all of
which can increase the risk of dementia.
Studies on whether parity affects the risk of dementia
are limited, and their results are different according to
study design and study population with different level of
parity. Some research suggests that more childbirths in-
creases the risk of dementia. A pooled analysis of two
population-based cohorts from South Korea and Greece
found that grand multiparous women had a 1.7-fold
higher risk of AD than women with 1 to 4 childbirths
[10], and a case-control study in Germany found that
nulliparity was less frequent in women with AD than in
cognitively normal women [11]. However, a prospective
cohort study in Italy found nulliparous women to show
a comparable risk of dementia to women with 1 to 4
childbirths [12], and an analysis of a claims database
from the USA found that women with 3 or more child-
births showed a lower risk of dementia than women giv-
ing birth only once (primiparous) [13].
In this study, we used the pooled data of 11
population-based prospective cohort studies from 11
countries over 3 continents to investigate whether parity
influences the risk of dementia, and whether there are
differences associated with geographic region and type
of dementia. Knowing whether parity affects the risk of
dementia will help to clarify sex and gender difference in
dementia and could identify a high-risk group in women.
With such a diverse overall sample, our study might also




We pooled baseline data for community-dwelling
women aged 60 or older from 11 members of the Co-
hort Studies of Memory in an International Consortium
(COSMIC) collaboration (Table 1) [14–25]. The partici-
pants were randomly sampled in all studies but the
Maastricht Ageing Study (MAAS). Although the Leipzig
Longitudinal Study of the Aged (LEILA 75+) included
both community-dwelling and institutionalized partici-
pants, we included the community sample only in the
present study. The included cohorts varied in size from
342 to 3919 participants. From an initial sample of 16,
296 women, we excluded 1504 who did not have data on
educational level, hypertension, DM, or parity, giving a
final sample of 14,792 women.
Measures
All studies provided data on dementia diagnosis, based on
DSM-IV criteria [26] in 10 studies and DSM-III-R criteria
[27] in one. Nine studies provided data on dementia sub-
types: AD according to the NINCDS-ADRDA criteria [28]
or DSM-IV criteria [26], and VaD according to the
NINDS-AIREN criteria [29] or DSM-IV criteria [26].
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Other data included parity, age, sex, educational level,
and presence of hypertension and DM which were all
harmonized when necessary. We assigned parity as the
number of childbirths in 6 cohorts and as the number of
children in 5 cohorts. When the participants adopted
and fostered children or their children died after birth,
the number of childbirths and children could be differ-
ent. However, only 3 among 590 women (0.3%) had dif-
ferent numbers for childbirths and children in Kurihara
study (KS) providing numbers for both childbirths and
children, and we used data on childbirth in these 3 cases.
To harmonize data on educational level, we classified it
into 3 categories. For nine studies with data on years of
education, we classified educational level as ≤ 6, 7 to 12,
or > 12 years. Three comparable education level groups
were used for the remaining two studies with categorical
data: primary school or under, secondary school, and
tertiary school or above. For hypertension and DM, we
used all available information from a study relevant to
diagnosing or classifying the condition. In a study with
limited information, hypertension and DM may be classi-
fied only from a medical history record, while for another
study, it may be indicated by any of self-reported history,
use of relevant medication, or measured blood pressure or
glucose level exceeding values indicated by international
guidelines. Four studies (Cuban Health and Alzheimer
Study [CHAS], Hellenic Longitudinal Investigation of
Aging and Diet [HELIAD], Korean Longitudinal Study on
Cognitive Aging and Dementia [KLOSCAD] and Sao
Paulo Ageing & Health Study [SPAH]) additionally
provided data on economic status, employment, and
length of reproductive years. Low economic status was de-
fined as lower 50% based on assets in the CHAS, less than
KRW 1,000,000 of monthly house income in the KLOS-
CAD, and BRL 360 or less of monthly house income in
the SPAH. In the HELIAD, 4 socioeconomic variables re-
garding a set of economic reserves or assets, holiday trav-
elling, and leisure time activities were used to define low
economic status [30]. Unemployment was defined as
“never been employed in lifetime” in all cohorts. The
length of reproductive years was calculated by subtracting
the age at menarche from the age at menopause.
Analysis
We initially examined the association between parity (0,
2, 3, 4, ≥ 5 vs 1) and the risk of all-cause dementia with
unadjusted and adjusted binary logistic regressions. The
adjusted model included age, educational level, hyper-
tension, DM, and cohort as covariates. We employed
primiparous women as the reference instead of nullipar-
ous women because nulliparity is associated with earlier
menopause [31], and women with earlier menopause had
an increased risk of dementia [32]. In obstetrics, 5 or more
parities and 10 or more parities are defined as grand mul-
tiparity and great grand multiparity, respectively, and they
were known to increase obstetric and neonatal complica-
tions [33]. Because the number of women with 5 or more
births was relatively low, we did not analyze each number
of births from 5 or more separately, but rather grouped
them into a grand multiparity group. In addition, we
Table 1 Contributing cohorts




CHAS15 Havana and Matanzas, Cuba 2003 Cuban 2944/1913/1552 75.1 ± 7.2 (65–100) 2.5 ± 2.2 (0–23)c 183/105/11
ESPRIT16 Montpellier, France 1999 White 2259/1313/1094 72.5 ± 5.6 (65–93) 2.4 ± 1.5 (0–9)cb 19/17/1
H7017 Gothenburg, Sweden 2000 White 1016/787/575 74.7 ± 5.4 (70–92) 2.0 ± 1.6 (0–20)c 16/7/4
HELIAD18 Larissa and Marousi, Greece 2009 White 1814/1074/918 72.1 ± 5.5 (60–93) 2.0 ± 0.8 (0–7)cb 22/16/3
KLOSCAD19 Nationwide, South Korea 2010 Asian 6818/3919/3686 70.7 ± 7.2 (60–101) 3.6 ± 1.7 (0–12)cb 190/145/17
KS20 Kurihara, Japan 2008 Asian 590/365/365 80.3 ± 4.2 (74–94) 2.4 ± 1.3 (0–7)cb 49/32/3
LEILA 75+21 Leipzig, Germany 1997 White 1265/964/636 81.2 ± 4.9 (75–99) 1.6 ± 1.3 (0–10)c 68/48/14
MAAS22 South Limburg, Netherlands 1993 White 683/342/342 69.2 ± 6.2 (60–82) 2.6 ± 1.9 (0–9)c 26/n.a./n.a.
SAS23 Shanghai, China 2010 Asian 3141/1873/1869 71.2 ± 8.4 (60–100) 2.0 ± 1.4 (0–9)cb 97/67/7
SPAH24 Sao Paulo, Brazil 2003 Brazilian 2072/1255/1149 72.6 ± 6.4 (65–101) 5.6 ± 4.1 (0–24)c 68/24/13
ZARADEMP25 Zaragoza, Spain 1994 White 4638/2683/2606 74.5 ± 9.6 (60–102) 2.4 ± 1.9 (0–12)cb 152/n.a./n.a.
CHAS Cuban Health and Alzheimer Study, ESPRIT Etude SanteÂ Psychologique et Traitement, H70 Gothenburg H70 Birth Cohort Studies, HELIAD Hellenic
Longitudinal Investigation of Aging and Diet, KLOSCAD Korean Longitudinal Study on Cognitive Aging and Dementia, KS Kurihara Study, LEILA75+ Leipzig
Longitudinal Study of the Aged, MAAS Maastricht Ageing Study, SAS Shanghai Aging Study, SPAH Sao Paulo Ageing & Health Study, ZARADEMP Zaragoza
Dementia Depression Project, AD Alzheimer’s disease, VaD vascular dementia, n.a. not available
The participants of all studies but MAAS were randomly sampled.
*Ethnicity of the country
†Numbers at the baseline assessment
‡Mean ± standard deviations (range)
cNumber of children
cbNumber of childbirths
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further classified grand multiparous women who gave 10
or more childbirths as a great grand multiparity group to
examine whether an extremely higher number of parity
additionally increase the risk of dementia. Next, we col-
lapsed women with 1 to 4 parities into a referent group
and compared this against nulliparity and grand multipar-
ity using the adjusted analyses described above. For 4 co-
horts with the additional data, we conducted analyses that
further adjusted for socioeconomic status, employment,
and reproductive years. We also used adjusted logistic re-
gression to investigate the association between parity as a
continuous variable and the risk of all-cause dementia.
The effects of parity and geographic region, and their
interaction, on the risk of all-cause dementia were inves-
tigated using a binary logistic regression. In this analysis,
we grouped parity into nulliparity, 1 to 4 parities, and
grand multiparity, and geographic region into Asia, Eur-
ope, and Latin America. We adjusted for age, educa-
tional level, hypertension, and DM.
We also conducted analyses within each geographic
region that examined how both nulliparity and grand
multiparity (vs 1 to 4 parities) were associated with (1)
the risk of all-cause dementia, using binary logistic re-
gressions, and (2) the risks of AD, VaD, and non-
Alzheimer non-vascular dementia (NAVD), using multi-
nomial logistic regressions. These analyses used data
from the 9 cohorts with information on dementia sub-
type. We excluded individuals with mixed etiologies
(2.5% of dementia) and adjusted for age, educational
level, hypertension, DM, and cohort.
The KLOSCAD team harmonized and pooled the
dataset and performed the analyses using the Statistical
Package for Social Sciences, v20 (SPSS Inc., Chicago, IL).
Results
The characteristics of the contributing cohorts are sum-
marized in Table 1. At least 10% of women were grand
multiparous in 5 cohorts and nulliparous in 4 cohorts.
Grand multiparity was more frequent in the Latin
American cohorts (28.6%) than in the Asian (17.8%) and
European (7.8%) cohorts. The Asian cohorts had less fre-
quent nulliparity (4.5%) than the European (14.3%) and
Latin American (11.2%) cohorts (Table 2). The preva-
lence of dementia was also different between regions.
The frequency of dementia was 10% or more in 3 co-
horts, and higher in the Latin American cohorts com-
pared to the Asian and European cohorts (P < 0.01).
When the prevalence of dementia subtypes was com-
pared separately, AD was less prevalent in the Asian co-
horts compared to the European and Latin American
cohorts while NAVD was more prevalent in the Latin
American cohorts compared to the Asian and European
cohorts (P < 0.01). Compared to women with 1 to 4 par-
ities, grand multiparous women were older (72.3 ± 7.7
years vs 75.6 ± 7.6 years, P < 0.01), showed higher pro-
portion of only primary or less education (44% vs 80%,
P < 0.01), and had more hypertension (65% vs 71%, P <
0.01) and DM (17% vs 24%, P < 0.01).
The number of parities was associated with hyperten-
sion and DM (Table 3). Compared to women with 1 to
4 parities, grand multiparous women were more likely to
have hypertension and DM (P < 0.01) and nulliparous
women showed a higher frequency of hypertension and
lower frequency of DM (P < 0.01).
Table 4 shows the risk of all-cause dementia associated
with parity determined with our initial analyses. In the
unadjusted logistic regression model, the risk of all-
cause dementia was not significantly different for nul-
liparous women and women with 2, 3, or 4 parities, but
was significantly higher for grand multiparous women
compared to primiparous women. In the logistic regres-
sion model adjusting for age, educational level, and co-
hort, grand multiparous women showed 1.47-fold higher
risk of all-cause dementia than primiparous women
(95% confidence interval [CI] = 1.11–1.94, P < 0.01).
When we further adjusted for hypertension and DM, the
association between grand multiparity and the risk for
all-cause dementia remained significant (OR = 1.47, 95%
CI = 1.10–1.94, P < 0.01). When we divided grand mul-
tiparous women into two groups, women with 5 to 9
parities and great grand multiparous women showed
1.44-fold (95% CI = 1.08–1.90, P = 0.01) and 1.86-fold
(95% CI = 1.11–3.09, P = 0.02) higher risks of all-cause
dementia, respectively. Further analyses with 1 to 4 par-
ities as the reference group found the risk of all-cause
dementia to be significantly higher in grand multiparous
women (odds ratio [OR] = 1.33, 95% CI = 1.09–1.60, P <
0.01) but not significantly different in nulliparous
women (OR = 0.83, 95% CI = 0.64–1.08, P = 0.16). The
results were similar when additionally adjusting for eco-
nomic status, employment, and reproductive years;
grand multiparity was associated with an increased risk
of all-cause dementia (OR = 1.46, 95% CI = 1.13–1.89,
P < 0.01), but nulliparity was not (OR = 1.07, 95% CI =
0.70–1.62, P = 0.77). An analysis with parity as a con-
tinuous variable showed the risk of all-cause dementia to
increase as the number of parities increased (OR = 1.06,
95% CI = 1.03–1.10, P < 0.01).
In further analyses, the risk of all-cause dementia was sig-
nificantly associated with parity (P < 0.01) and geographic
region (P < 0.01), as well as their interaction (P < 0.01). As
seen in Table 5, compared to women with 1 to 4 parities,
grand multiparous women showed about 3-fold and 1.5-
fold higher risk of all-cause dementia in the European (P <
0.01) and Latin American (P = 0.03) cohorts. Grand multip-
arous women also showed a modestly higher risk of all-
cause dementia in the Asian cohorts, but this was not
statistically significant (P = 0.24). Nulliparous women
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showed about 2-fold higher risk of all-cause dementia than
women with 1 to 4 parities in the Asian cohorts (P < 0.01),
but associations with nulliparity were not statistically sig-
nificant in the European (P = 0.66) and Latin American
(P = 0.26) cohorts.
The results of analyses examining how grand multipar-
ity and nulliparity were associated with the risks of AD,
VaD, and NAVD separately in each geographic region
are also shown in Table 5. Compared to women with 1
to 4 parities, grand multiparity was associated with a










F or χ2 P Post hoc*
Age, mean ± SD, years 73.1 ± 7.9 71.4 ± 7.8 74.2 ± 8.0 74.0 ± 7.0 217.79 < 0.001 a < b, a < c
Educational level, % 1049.72 < 0.001 –
≤ 6 years or primary school or under 48.8 46.6 39.4 75.0
7 to 12 years or secondary school 38.8 39.0 48.4 16.1
> 12 years or tertiary school or above 12.5 14.4 12.2 12.2
Hypertension, % 66.5 55.7 71.2 79.2 569.22 < 0.001 a < b, a < c, b < c
Diabetes mellitus, % 17.3 16.6 12.7 29.5 375.205 < 0.001 a > b, a < c, b < c
Parity (continuous), mean ± SD 2.8 ± 2.2 3.0 ± 1.8 2.3 ± 1.6 3.8 ± 3.5 512.99 < 0.001 a > b, a < c, b < c
Parity (categorical), % 949.73 < 0.001
0 (nulliparity) 9.8 4.5 14.3 11.2
1 to 4 74.6 77.8 77.9 60.2
≥ 5 (grand multiparity) 15.6 17.8 7.8 28.6
Dementia prevalence, % 5.9 5.7 4.7 9.1 64.60 < 0.001 a < c, b < c
Dementia subtypes,† % 54.14 < 0.001 –
AD 4.0 3.1 4.1 4.8
VD 0.6 0.7 0.5 0.9
NAVD 1.4 0.4 0.9 3.3
SD standard deviation, AD Alzheimer’s disease, VaD vascular dementia, NAVD non-Alzheimer non-vascular dementia
*Continuous variables were compared using analysis of variance, and categorical variables were compared using the χ2 test. Post hoc comparisons were based on
Scheffé’s theorem: a = Asia; b = Europe; c = Latin America
†Estimated using 9 cohorts providing data on dementia subtypes
Table 3 Comparison of the cohort characteristics between three parity groups
Characteristics Number of parities Statistics*
0 1 to 4 ≥ 5 F or χ2 P Post hoc*
Age, mean ± SD, years 74 ± 8.3 72.3 ± 7.7 75.6 ± 7.7 224.345 < 0.001 a > b, a < c, b < c
Educational level, % 1122.978 < 0.001 –
≤ 6 years or primary school or under 36.5 43.9 80.0
7 to 12 years or secondary school 44.4 42.6 17.1
> 12 years or tertiary school or above 19.1 13.6 2.9
Hypertension, % 69.3 65.2 70.9 33.289 < 0.001 a > b, b < c
Diabetes mellitus, % 13.1 16.5 23.5 84.376 < 0.001 a < b, a < c, b < c,
Dementia prevalence, % 5.8 5.0 10.5 103.961 < 0.001 a < c, b < c,
Dementia subtypes,† % 112.556 < 0.001 –
AD 4.6 3.1 7.1
VD 0.6 0.5 1.1
NAVD 2.2 1.0 2.4
*Continuous variables were compared using analysis of variance, and categorical variables were compared using the χ2 test. Post hoc comparisons were based on
Scheffé’s theorem: a = nulliparity; b = 1 to 4 parities; c = grand multiparity
†Estimated using 9 cohorts providing data on dementia subtypes
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more than 6-fold higher risk of VaD in the European co-
horts (P < 0.01) and about a 1.8-fold higher risk of
NAVD in the Latin American cohorts (P = 0.03). Nulli-
parity was associated with about a 1.9-fold higher risk of
AD (P = 0.03) and about a 3.5-fold higher risk of NAVD
(P < 0.01) in the Asian cohorts. However, the associa-
tions between nulliparity and the risk of AD, VaD, and
NAVD were not statistically significant in other geo-
graphic regions.
Discussion
This study included nearly 15,000 community-dwelling
elderly women from 11 population-based prospective
cohort studies from 11 countries over 3 continents and
found that grand multiparity and nulliparity were associ-
ated with an increased risk of dementia. However, these
associations were not uniform across different geo-
graphic regions or dementia subtypes. Grand multiparity
was associated with an increased risk of VaD in Euro-
pean cohorts and an increased risk of NAVD in Latin
American cohorts. Conversely, nulliparity was associated
with an increased risk of both AD and NAVD in Asian
cohorts.
The association between grand multiparity and the
risk of all-cause dementia has not been previously inves-
tigated. Gilsanz et al., using a claims database that
included 14,595 women (Caucasian 68%, African Ameri-
can 16%, Asian 6%, and Hispanic 5%), reported that
women with 3 or more childbirths showed modestly
lower risk of all-cause dementia (hazard ratio = 0.88,
95% CI = 0.81–0.95) than primiparous women [13].
However, they did not specifically analyze the associ-
ation between grand multiparity and the risk of all-cause
dementia, and their dementia diagnoses were derived
from the billing codes of electronic medical records,
which may lack diagnostic accuracy [34]. Their results
thus cannot be directly compared against our finding
that grand multiparity increased the risk of dementia. It
has been previously reported that grand multiparous
women are more likely to have risk factors for dementia
that include being less educated, unemployed, and eco-
nomically disadvantaged [6], experiencing more stress
during childbearing, and higher rates of medical condi-
tions such as coronary heart disease, stroke, DM, and
metabolic syndrome [7–9]. This is consistent with the
data we had showing less education and higher rates of
hypertension and DM in grand multiparous women. Re-
petitive pregnancies and childbirths may also have direct
cumulative harmful effects on the brain. For example,
serum estradiol increases more than 10-fold and insulin
sensitivity drops to 50% in the third trimester, with both
effects potentially neurotoxic [35, 36]. Gray matter vol-
umes in multiple areas including the hippocampus were
reduced and persisted for 2 years after birth [37]. Density
and numbers of microglia which is known to contribute
to neurogenesis and spinogenesis were reduced during
peripartum period, and its proliferation was reduced in
the postpartum hippocampus [38]. In addition, serum
estrogen was reduced after pregnancy in both premeno-
pausal and postmenopausal periods [39, 40].
The number of people with dementia is expected to
more than double in Africa, Asia, and Latin America,
and the global proportion of individuals with dementia
living in these regions will have increased to about 70%
by 2050 [41]. Women in these regions have typically had
much higher fertility rates than women in Europe and
North America [42]. Despite the global fertility rate hav-
ing fallen by half in the last 60 years or so (from 5 to 2.5
births per woman), it remains at around five in most
African countries [41]. While this suggests that grand
multiparity may be a risk factor for dementia of particu-
lar importance to Africa, further research is needed
given our lack of African cohorts and findings of geo-
graphic differences.
Although grand multiparity was associated with an in-
creased risk of dementia both in European and Latin
Table 4 The risk of all-cause dementia associated with parity
Parity Number of subjects Unadjusted model Adjusted model I* Adjusted model II†
Control Dementia OR (95% CI) P OR (95% CI) P OR (95% CI) P
0 (nulliparity) 1368 84 1.25 (0.93–1.68) 0.014 0.91 (0.66–1.25) 0.560 0.92 (0.67–1.27) 0.613
1 (primiparity) 2096 103 1.00 [Reference] 1.00 [Reference] 1.00 [Reference]
2 3923 181 0.94 (0.73–1.20) 0.618 1.12 (0.86–1.46) 0.397 1.13 (0.86–1.47) 0.375
3 2819 161 1.16 (0.90–1.50) 0.245 1.19 (0.91–1.57) 0.206 1.19 (0.91–1.57) 0.200
4 1652 103 1.27 (0.96–1.68) 0.096 1.06 (0.79–1.44) 0.690 1.07 (0.79–1.45) 0.664
≥ 5 (grand multiparity) 2061 241 2.38 (1.87–3.02) < 0.001 1.47 (1.11–1.94) 0.007 1.47 (1.10–1.94) 0.007
5 to 9 1836 212 2.35 (1.84–3.00) < 0.001 1.43 (1.08–1.90) 0.012 1.44 (1.08–1.90) 0.012
≥ 10 225 29 2.62 (1.70–4.05) < 0.001 1.84 (1.11–3.06) 0.019 1.86 (1.11–3.09) 0.018
OR odds ratio, CI confidence intervals
*Binary logistic regression analyses adjusted for age, educational level, and cohort as covariates
†Binary logistic regression analyses adjusted for age, educational level, hypertension, diabetes mellitus, and cohort as covariates
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American cohorts, the association was not significant in
Asian cohorts. There were also differences associated
with dementia subtype. Grand multiparity was associated
with a more than 6-fold higher risk of VaD in European
cohorts, and about a 2-fold risk of NAVD in Latin
American cohorts. Different associations between grand
multiparity and dementia risk by geographic region and
dementia subtype might be due to different ethno-racial
susceptibilities of the hormonal and vascular system to
the effects of pregnancy or childbirth. For example, it
has been previously reported that the number of parities
influenced gestational period estradiol levels in Cauca-
sian women, but not in Asian women [43], and that the
risks of gestational hypertension and preeclampsia were
higher in Caucasian women than in Asian/Pacific
Islanders and Hispanic women [44]. Insulin resistance,
which was more prevalent in postmenopausal women
with 4 or more children compared to those with 0–3
parities [45], may influence the risk of dementia in
European regions where DM was less prevalent com-
pared to the Asian and Latin American regions. Al-
though we could not adjust the effect of apolipoprotein
E genotype in the present study, different distribution of
apolipoprotein E genotype and psychosocial stresses as-
sociated with childbearing between regions may possibly
contribute to the different association between grand
multiparity and the risk of dementia between regions.
In contrast to grand multiparity being associated with
an increased risk of dementia in both the European and
Latin American cohorts, only in Asian cohorts was nulli-
parity associated with a higher risk of dementia, particu-
larly non-vascular dementia. In the current study, the
proportion of VaD in all-cause dementia was higher in
the European cohorts (18%) than in Asian (8.3%) and
Latin American (9.9%) cohorts. This inter-regional dif-
ference in the association between nulliparity and the
risk of dementia may be, at least in part, attributable to
an inter-regional difference in the causes of nulliparity.
In the current study, the proportion of nulliparous
women in Asian cohorts (4.5%) was much lower than
that in European (14.3%) and Latin American (11.2%)
cohorts, and nonmarriage and voluntary childlessness in
nulliparous women are less common in Asian countries
compared to the Western countries [46]. Therefore, nul-
liparous women in Asia are more likely to have involun-
tary factors as causes of nulliparity. The majority of
involuntary causes of nulliparity are infertility and recur-
rent miscarriage. The most common cause of infertility
is ovulatory dysfunction caused by premature ovarian
failure, ovarian hyperandrogenism, hypothalamic dys-
function, pituitary disease, and thyroid disease [47], and
these conditions are reportedly associated with the risk
of cognitive impairment or AD [48]. Furthermore,
women experiencing recurrent miscarriage are more
likely to have the apolipoprotein E ε4 allele, which con-
veys an increased risk of AD [49].
The current study has limitations. First, we could not
adjust for some well-known associated factors for de-
mentia such as apolipoprotein E genotype, diet, repro-
ductive experiences such as breast feeding, and
gynecological surgery that could be associated with par-
ity. However, in our previous work, the association be-
tween parity and AD remained significant even after
adjusting for breast feeding, history of hormonal replace-
ment therapy, hysterectomy, and oophorectomy [10].
Second, the data harmonization procedure might have
confounded our observations. For example, parity data
was based on the number of childbirths in 6 cohorts and
the number of children in 5 cohorts, and adoption or
death of children might have distorted parity informa-
tion. However, this would likely apply to only a very
small number of cases, given that for our KS, only 0.3%
of women had different numbers for childbirths and
children. Third, information on parity was obtained
retrospectively. However, childbirths are life events not
easily forgotten and likely to be minimally prone to re-
call bias. Fourth, regional difference in the diagnostic
rates of dementia and its subtypes might have influenced
the differential associations of parity with dementia sub-
types according to geographical regions because the
prevalence of dementia subtypes was considerably differ-
ent between geographical regions. Fifth, women with
middle- and late-stage dementia might be less likely to
be included in the present study because all participants
were community-dwelling.
Conclusions
Grand multiparity and nulliparity are associated with the
risk of dementia in women, but these associations were
not uniform across geographic regions and dementia
subtypes. The findings of this study help to understand
the development of dementia in women, and have im-
portant implications for world regions where the birth
rate remains high.
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